Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) Transcript
I am Raj Prasad. I am on the biotech team here at William Blair, and I cover Beam Therapeutics. Before we begin, I just have to tell you, for a list of disclosures or conflicts of interest, see our website at williamblair.com. And with that, glad to have you, John. Lots of things going on at Beam.
So maybe just to start and provide a foundation for the conversation, a brief overview of the Company and of base editing technology and where it has come from and where it is now.
Great. Yes. Thanks for having us, excited to see you again.
So Beam was founded to be focusing on next-generation technology within gene editing, specifically initially called base editing. So we were founded in 2017 by leaders in the CRISPR field, so this is David Liu, Feng Zhang and Keith Joung.
And stepping back, if you think about where the CRISPR field comes from: so gene editing, we have zinc fingers; we have TALENs; and then of course CRISPR
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
